PRIMECAP MANAGEMENT CO 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 1:28 pm Sale | 2023-06-30 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 8,149,876 4.310% | -7,509,177 (-47.95%) | Filing |
| 2023-02-09 4:01 pm Sale | 2022-12-31 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 15,659,053 8.330% | -1,753,369 (-10.07%) | Filing |
| 2022-02-10 12:26 pm Sale | 2021-12-31 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 17,412,422 9.430% | -1,027,977 (-5.57%) | Filing |
| 2021-02-12 12:02 pm Sale | 2009-02-28 | 13G | Nektar Therapeutics NKTR | PRIMECAP MANAGEMENT CO | 18,440,399 10.280% | -1,639,949 (-8.17%) | Filing |